Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Return on Sales: 2009-2024

Historic Return on Sales for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to 0.42%.

  • UNITED THERAPEUTICS's Return on Sales rose 13.00% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 13.00%. This contributed to the annual value of 0.42% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Return on Sales of 0.42% as of FY2024, which was down 1.84% from 0.42% recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Return on Sales high stood at 0.42% for FY2023, and its period low was 0.28% during FY2021.
  • In the last 3 years, UNITED THERAPEUTICS's Return on Sales had a median value of 0.42% in 2024 and averaged 0.40%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 42bps in 2020, then fell by 6bps in 2021.
  • Over the past 5 years, UNITED THERAPEUTICS's Return on Sales (Yearly) stood at 0.35% in 2020, then fell by 6bps to 0.28% in 2021, then climbed by 9bps to 0.38% in 2022, then climbed by 5bps to 0.42% in 2023, then decreased by 1bps to 0.42% in 2024.